Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioceres Crop Solutions (BIOX) EBITDA Margin (2021 - 2026)

Bioceres Crop Solutions' EBITDA Margin history spans 4 years, with the latest figure at 25.39% for Q1 2026.

  • On a quarterly basis, EBITDA Margin fell 2060.0% to 25.39% in Q1 2026 year-over-year; TTM through Mar 2026 was 22.9%, a N/A change, with the full-year FY2025 number at 1.13%, down 998.0% from a year prior.
  • EBITDA Margin hit 25.39% in Q1 2026 for Bioceres Crop Solutions, down from 4.79% in the prior quarter.
  • Over the last five years, EBITDA Margin for BIOX hit a ceiling of 4.79% in Q1 2025 and a floor of 77.68% in Q2 2022.
  • Historically, EBITDA Margin has averaged 35.96% across 3 years, with a median of 25.39% in 2026.
  • Biggest five-year swings in EBITDA Margin: skyrocketed 185346bps in 2022 and later plummeted -2060bps in 2026.
  • Tracing BIOX's EBITDA Margin over 3 years: stood at 77.68% in 2022, then surged by 94bps to 4.79% in 2025, then crashed by -430bps to 25.39% in 2026.
  • Business Quant data shows EBITDA Margin for BIOX at 25.39% in Q1 2026, 4.79% in Q1 2025, and 77.68% in Q2 2022.